Intended for healthcare professionals

  1. Research
  2. Prospective cohort...
  3. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness
Papers

Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness

BMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7244.1236 (Published 06 May 2000) Cite this as: BMJ 2000;320:1236

Related articles

See more

Cited by...

  • Screening and management of atrial fibrillation in primary care
  • Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR(R)) PINNACLE Registry
  • Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score-Matched Analysis of 10 633 Patients
  • Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review
  • The Clinical Profile and Pathophysiology of Atrial Fibrillation: Relationships Among Clinical Features, Epidemiology, and Mechanisms
  • Incidence, Predictors, and Prognostic Implications of Hospitalization for Late Bleeding After Percutaneous Coronary Intervention for Patients Older Than 65 Years
  • Racial Disparities in Awareness and Treatment of Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
  • Can the NICE guidelines on the management of atrial fibrillation improve its management?
  • Atrial fibrillation in a primary care population: how close to NICE guidelines are we?
  • Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation: A Systematic Review
  • Letter Regarding Article by Hylek et al, "Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation"
  • Antithrombotic treatment in atrial fibrillation
  • The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study
  • Eligibility for Anticoagulation in Elderly Patients With Atrial Fibrillation
  • Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation
  • Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin
  • Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population
  • Importance of risk communication and decision making in cardiovascular conditions in older patients: a discussion paper
  • Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database
  • Anticoagulation and atrial fibrillation
  • Anticoagulation to prevent stroke in atrial fibrillation
  • Anticoagulation for patients with atrial fibrillation
  • Secondary Stroke Prevention in Atrial Fibrillation : Lessons From Clinical Practice
  • Anticoagulation for AF in Clinical Practice
  • Anticoagulation in Atrial Fib Works as Well in Practice as in Trials
  • Anticoagulation for patients with atrial fibrillation and risk factors for stroke
Back to top